Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis

References

• Alavi, M., Grebely, J., Matthews, G. V., Petoumenos, K., Yeung, B., Day, C., … Haber, P. S. (2012). Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27, 957–965. doi:10.1111/j.1440-1746.2011.07035.x
   PubMed Web of Science ®Google Scholar
• Backus, L. I., Boothroyd, D., & Deyton, L. R. (2005). HIV, hepatitis C and HIV/Hepatitis C virus co-infection in vulnerable populations. AIDS, 19(Suppl. 3), S13–S19. doi:10.1097/01.aids.0000192065.09281.01
   PubMed Web of Science ®Google Scholar
• Baillargeon, J. G., Paar, D. P., Wu, H., Giordano, T. P., Murray, O., Raimer, B. G., … Pulvino, J. S. (2008). Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting. AIDS Care, 20, 124–129. doi:10.1080/09540120701426532
   PubMed Web of Science ®Google Scholar
• Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., … Campa, A. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Diseases, 27, 37–48. doi:10.1300/J069v27n02_05
   PubMed Web of Science ®Google Scholar
• Braitstein, P., Montessori, V., Chan, K., Montaner, J. S., Schechter, M. T., O’Shaughnessy, M. V., & Hogg, R. S. (2005). Quality of life, depression and fatigue among persons co infected with HIV and hepatitis C: Outcomes from a population based cohort. AIDS Care, 17, 505–515. doi:10.1080/09540120412331291733
   PubMed Web of Science ®Google Scholar
• Butt, A. A., Justice, A. C., Skanderson, M., Good, C., & Kwoh, C. K. (2006). Rates and predictors of hepatitis C virus treatment in HCV–HIV-coinfected subjects. Alimentary Pharmacology & Therapeutics, 24, 585–591. doi:10.1111/j.1365-2036.2006.03020.x
   PubMed Web of Science ®Google Scholar
• Butt, A. A., Khan, U. A., Shaikh, O. S., McMahon, D., Dorey-Stein, Z., Tsevat, J., Lo Re, V., III. (2009). Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers. HIV Clinical Trials, 10, 25–32. doi:10.1310/hct1001-025
   PubMed Web of Science ®Google Scholar
• Chen, T. Y., & Jain, M. K. (2015). Treatment of hepatitis C in HIV-infected patients: Moving towards an era of all oral regimens. AIDS Patient Care and STDs, 29, 329–337. doi:10.1089/apc.2014.0247
   PubMed Web of Science ®Google Scholar
• Ciccarelli, N., Fabbiani, M., Grima, P., Falasca, K., Tana, M., Baldonero, E., … Di Giambenedetto, S. (2013). Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients. Infection, 41, 1103–1109. doi:10.1007/s15010-013-0503-2
   PubMed Web of Science ®Google Scholar
• Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158, 725–730. doi:10.1176/appi.ajp.158.5.725
   PubMed Web of Science ®Google Scholar
• Clifford, D. B., Evans, S. R., Yang, Y., & Gulick, R. M. (2005). The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS, 19(Suppl. 3), S64–S71. doi:10.1097/01.aids.0000192072.80572.43
   PubMed Web of Science ®Google Scholar
• Forton, D. M., Hamilton, G., Allsop, J. M., Grover, V. P., Wesnes, K., O’Sullivan, C., … Taylor-Robinson, S. D. (2008). Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. Journal of Hepatology, 49, 316–322. doi:10.1016/j.jhep.2008.03.022
   PubMed Web of Science ®Google Scholar
• Fumaz, C. R., Muñoz-Moreno, J. A., Ballesteros, A. L., Paredes, R., Ferrer, M. J., Salas, A., … Clotet, B. (2007). Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV–HCV coinfected patients. AIDS Care, 19, 138–145. doi:10.1080/09540120600645539
   PubMed Web of Science ®Google Scholar
• Goulet, J. L., Fultz, S. L., Mcginnis, K. A., & Justice, A. C. (2005). Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS, 19(Suppl. 3), S99–S105. doi:10.1097/01.aids.0000192077.11067.e5
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. Retrieved from www.cochrane-handbook.org
   Google Scholar
• Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557–560. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Jones, K. A., & Thomsen, C. (2013). The role of the innate immune system in psychiatric disorders. Molecular and Cellular Neuroscience, 53, 52–62. doi:10.1016/j.mcn.2012.10.002
   PubMed Web of Science ®Google Scholar
• Kemmer, N., Hua, L., Andersen, J. W., Chung, R. T., Butt, A. A., & Sherman, K. E. (2012). Health-related quality of life in subjects with HCV/HIV coinfection: Results from ACTG 5178 study. Journal of Viral Hepatitis, 19, 792–800. doi:10.1111/j.1365-2893.2012.01609.x
   PubMed Web of Science ®Google Scholar
• Klein, M. B., Lee, T., Brouillette, M. J., Sheehan, N. L., Walmsley, S., Wong, D. K., … Singer, J. (2014). Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: A multicenter randomized double-blind placebo-controlled trial. HIV Clinical Trials, 15, 161–175. doi:10.1310/hct1504-161
   PubMed Web of Science ®Google Scholar
• Laguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., … Mallolas, J. (2004). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS, 18, 27–36. doi:10.1097/00002030-200409030-00003
   Web of Science ®Google Scholar
• Landau, A., Batisse, D., Piketty, C., Paul, J., Van Huyen, D., Bloch, F., … Kazatchkine, M. D. (2001). Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients. AIDS, 15, 2149–2155.10.1097/00002030-200111090-00010
   PubMed Web of Science ®Google Scholar
• Leutscher, P. D. C., Lagging, M., Buhl, M. R., Pedersen, C., Norkrans, G., Langeland, N., … Bech, P. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology, 52, 430–435. doi:10.1002/hep.23699
   PubMed Web of Science ®Google Scholar
• Martin-Subero, M., & Diez-Quevedo, C. (2016). Mental disorders in HIV/HCV coinfected patients under antiviral treatment for hepatitis C. Psychiatry Research, 246, 173–181. doi:10.1016/j.psychres.2016.09.041
   PubMed Web of Science ®Google Scholar
• Michel, L., Villes, V., Dabis, F., Spire, B., Winnock, M., Loko, M. A., … Carrieri, M. P. (2010). Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV–HCV co-infected patients: ANRS Co13 Hepavih, France, 2006–2008. Journal of Viral Hepatitis, 17, 650–660. doi:10.1111/j.1365-2893.2009.01223.x
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6, e1000097. doi:10.1371/journal.pmed1000097
   PubMed Web of Science ®Google Scholar
• Moreno, L., Quereda, C., Moreno, A., Perez-Elías, M. J., Antela, A., Casado, J. L., … Moreno, S. (2004). Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS, 18, 67–73. doi:10.1097/00002030-200401020-00008
   PubMed Web of Science ®Google Scholar
• Myers, R. P., Benhamou, Y., Bochet, M., Thibault, V., Mehri, D., & Poynard, T. (2004). Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy. AIDS, 18, 75–79. doi:10.1097/00002030-200401020-00009
   PubMed Web of Science ®Google Scholar
• Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015). Depression in HIV infected patients: A review. Current Psychiatry Reports, 17, 530. doi:10.1007/s11920-014-0530-4
   PubMed Web of Science ®Google Scholar
• Nasi, M., Pinti, M., Mussini, C., & Cossarizza, A. (2014). Persistent inflammation in HIV infection: Established concepts, new perspectives. Immunology Letters, 161, 184–188. doi:10.1016/j.imlet.2014.01.008
   PubMed Web of Science ®Google Scholar
• O’Cleirigh, C., Newcomb, M. E., Mayer, K. H., Skeer, M., Traeger, L., & Safren, S. A. (2013). Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: A longitudinal analysis of data from six sites involved in a “prevention for positives” study. AIDS and Behavior, 17, 1764–1769. doi:10.1007/s10461-013-0462-8
   PubMed Web of Science ®Google Scholar
• Pantalone, D. W., Hessler, D. M., Bankoff, S. M., & Shah, B. J. (2012). Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men. Journal of Behavioral Medicine, 35, 520–528. doi:10.1007/s10865-011-9381-1
   PubMed Web of Science ®Google Scholar
• Pereira, M., Fialho, R., & Canavarro, M. C. (2014). Prevalence and correlates of emotional distress in HIV/HCV coinfection. AIDS Care, 26(Suppl. 1), S56–S64. doi:10.1080/09540121.2014.906549
   PubMed Web of Science ®Google Scholar
• Raison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., … Miller, A. H. (2009). Activation of central nervous system inflammatory pathways by interferon-alpha: Relationship to monoamines and depression. Biological Psychiatry, 65, 296–303. doi:10.1016/j.biopsych.2008.08.010
   PubMed Web of Science ®Google Scholar
• Richardson, J. L., Nowicki, M., Danley, K., Martin, E. M., Cohen, M. H., Gonzalez, R., … Levine, A. M. (2005). Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. AIDS, 19, 1659–1667. doi:10.1097/01.aids.0000186824.53359.62
   PubMed Web of Science ®Google Scholar
• Rockstroh, J. K., Mudar, M., Lichterfeld, M., Nischalke, H. D., Klausen, G., Gölz, J., … Mauss, S. (2002). Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients. AIDS, 16, 2083–2085. doi:10.1097/00002030-200210180-00016
   PubMed Web of Science ®Google Scholar
• Roux, P., Lions, C., Cohen, J., Winnock, M., Salmon-Céron, D., Bani-Sadr, F., … Carrieri, M. P. (2013). Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV–HCV patients: Results from the ANRS-CO13-HEPAVIH cohort. Antiviral Therapy. Advance online publication. doi:10.3851/IMP2699
   PubMed Web of Science ®Google Scholar
• Ryan, E. L., Morgello, S., Isaacs, K., Naseer, M. G., Gerits, P., & Manhattan HIV Brain Bank (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62, 957–962. doi:10.1212/01.WNL.0000115177.74976.6C
   PubMed Web of Science ®Google Scholar
• Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., … Pariante, C. M. (2012). Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement. Journal of Hepatology, 57, 1379–1390. doi:10.1016/j.jhep.2012.07.037
   PubMed Web of Science ®Google Scholar
• Silberbogen, A. K., Ulloa, E. W., Janke, E. A., & Mori, D. L. (2009). Psychosocial issues and mental health treatment recommendations for patients with hepatitis C. Psychosomatics, 50, 114–122. doi:10.1176/appi.psy.50.2.114
   PubMed Web of Science ®Google Scholar
• Slot, M., Sodemann, M., Gabel, C., Holmskov, J., Laursen, T., & Rodkjaer, L. (2015). Factors associated with risk of depression and relevant predictors of screening for depression in clinical practice: A cross-sectional study among HIV-infected individuals in Denmark. HIV Medicine, 16, 393–402. doi:10.1111/hiv.12223
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S., Felizarta, F., Smith, C., Slim, J., Berggren, R., Goodman, R., & Hepatitis Resource Network Clinical Trials Group. (2004). Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: A multicenter randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 35, 464–472. doi:10.1097/00126334-200404150-00004
   PubMed Web of Science ®Google Scholar
• Sun, B., Abadjian, L., Rempel, H., Monto, A., & Pulliam, L. (2013). Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62, 190–196. doi:10.1097/QAI.0b013e31827b61f1
   PubMed Web of Science ®Google Scholar
• Tavakkoli, M., Ferrando, S. J., Rabkin, J., Marks, K., & Talal, A. H. (2013). Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection. Psychosomatics, 54, 466–471. doi:10.1016/j.psym.2013.02.009
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. (2014). Review Manager (RevMan) [Computer program], version 5.3. Copenhagen: The Nordic Cochrane Centre.
   Google Scholar
• Thein, H., Maruff, P., Krahn, M., Kaldor, J., Koorey, D., Brew, B., & Dore, G. (2007). Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. HIV Medicine, 8, 192–202. doi:10.1111/j.1468-1293.2007.00452.x
   PubMed Web of Science ®Google Scholar
• Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., … Martín-Santos, R. (2012). Interferon-induced depression in chronic hepatitis C. The Journal of Clinical Psychiatry, 73, 1128–1138. doi:10.4088/JCP.12r07694
   PubMed Web of Science ®Google Scholar
• Uher, R., Perlis, R. H., Placentino, A., Dernovšek, M. Z., Henigsberg, N., Mors, O., … Farmer, A. (2012). Self-report and clinician-rated measures of depression severity: Can one replace the other? Depression and Anxiety, 29, 1043–1049. doi:10.1002/da.21993
   PubMed Web of Science ®Google Scholar
• van de Laar, T. J., Matthews, G. V., Prins, M., & Danta, M. (2010). Acute hepatitis C in HIV-infected men who have sex with men: An emerging sexually transmitted infection. AIDS, 24, 1799–1812. doi:10.1097/QAD.0b013e32833c11a5
   PubMed Web of Science ®Google Scholar
• von Giesen, H.-J., Heintges, T., Abbasi-Boroudjeni, N., Kücükköylü, S., Köller, H., Haslinger, B. A., … Arendt, G. (2004). Psychomotor slowing in hepatitis C and HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 35, 131–137. doi:10.1097/00126334-200402010-00005
   PubMed Web of Science ®Google Scholar
• Wahl, I., Löwe, B., Bjorner, J. B., Fischer, F., Langs, G., Voderholzer, U., … Rose, M. (2014). Standardization of depression measurement: A common metric was developed for 11 self-report depression measures. Journal of Clinical Epidemiology, 67, 73–86. doi:10.1016/j.jclinepi.2013.04.019
   PubMed Web of Science ®Google Scholar
• Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schüler, A., Ennen, J. C., … Böker, K. W. (2004). Hepatitis C virus infection affects the brain – Evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41, 845–851. doi:10.1016/j.jhep.2004.07.022
   PubMed Web of Science ®Google Scholar
• Yoon, J. C., Crane, P. K., Ciechanowski, P. S., Harrington, R. D., Kitahata, M. M., & Crane, H. M. (2011). Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients. AIDS Care, 23, 1208–1218. doi:10.1080/09540121.2011.555739
   PubMed Web of Science ®Google Scholar